Dr. Lal PathLabs Limited (LALPATHLAB.BO)
INR 3018.95
(-0.63%)
INR 3018.95
(-0.63%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14.62 Billion INR | -43.04% |
| 2022 | 15.69 Billion INR | -0.97% |
| 2021 | 15.85 Billion INR | 61.8% |
| 2020 | 9.79 Billion INR | -5.04% |
| 2019 | 10.31 Billion INR | 9.63% |
| 2018 | 9.41 Billion INR | 13.26% |
| 2017 | 8.3 Billion INR | 16.16% |
| 2016 | 7.15 Billion INR | 15.67% |
| 2015 | 6.18 Billion INR | 18.82% |
| 2014 | 5.2 Billion INR | 18.2% |
| 2013 | 4.4 Billion INR | 24.25% |
| 2012 | 3.54 Billion INR | 33.2% |
| 2011 | 2.66 Billion INR | 50.82% |
| 2010 | 1.76 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.47 Billion INR | 13.07% |
| 2024 Q2 | 4.39 Billion INR | 13.09% |
| 2023 FY | 8.94 Billion INR | -43.04% |
| 2023 Q3 | 3.54 Billion INR | -10.03% |
| 2023 Q2 | 3.93 Billion INR | 11.4% |
| 2023 Q1 | 3.53 Billion INR | -8.23% |
| 2023 Q4 | 2.18 Billion INR | -38.2% |
| 2022 Q2 | 3.43 Billion INR | 7.65% |
| 2022 Q4 | 3.85 Billion INR | 24.55% |
| 2022 FY | 15.69 Billion INR | -0.97% |
| 2022 Q3 | 3.09 Billion INR | -9.93% |
| 2022 Q1 | 3.18 Billion INR | 266.61% |
| 2021 Q1 | 3.69 Billion INR | 12.72% |
| 2021 FY | 15.85 Billion INR | 61.8% |
| 2021 Q4 | 869.87 Million INR | -76.99% |
| 2021 Q2 | 3.04 Billion INR | -17.68% |
| 2021 Q3 | 3.78 Billion INR | 24.3% |
| 2020 Q3 | 3.42 Billion INR | 5.87% |
| 2020 Q1 | 1.9 Billion INR | -17.22% |
| 2020 Q2 | 3.23 Billion INR | 70.23% |
| 2020 Q4 | 3.27 Billion INR | -4.35% |
| 2020 FY | 9.79 Billion INR | -5.04% |
| 2019 Q4 | 2.29 Billion INR | -9.41% |
| 2019 Q3 | 2.53 Billion INR | -10.9% |
| 2019 Q2 | 2.84 Billion INR | 7.77% |
| 2019 FY | 10.31 Billion INR | 9.63% |
| 2019 Q1 | 2.64 Billion INR | 11.88% |
| 2018 Q4 | 2.35 Billion INR | 3.86% |
| 2018 Q2 | 2.49 Billion INR | 9.51% |
| 2018 Q1 | 2.28 Billion INR | 8.98% |
| 2018 FY | 9.41 Billion INR | 13.26% |
| 2018 Q3 | 2.27 Billion INR | -9.05% |
| 2017 Q2 | 2.18 Billion INR | 10.9% |
| 2017 Q4 | 2.09 Billion INR | 1.75% |
| 2017 Q1 | 1.97 Billion INR | 12.75% |
| 2017 FY | 8.3 Billion INR | 16.16% |
| 2017 Q3 | 2.05 Billion INR | -5.94% |
| 2016 Q4 | 1.74 Billion INR | 7.04% |
| 2016 FY | 7.15 Billion INR | 15.67% |
| 2016 Q2 | 2.02 Billion INR | 16.17% |
| 2016 Q1 | 1.74 Billion INR | 12.84% |
| 2016 Q3 | 1.63 Billion INR | -19.35% |
| 2015 Q1 | 1.49 Billion INR | 11.24% |
| 2015 Q3 | 1.46 Billion INR | -12.1% |
| 2015 Q4 | 1.54 Billion INR | 5.2% |
| 2015 FY | 6.18 Billion INR | 18.82% |
| 2015 Q2 | 1.67 Billion INR | 11.6% |
| 2014 FY | 5.2 Billion INR | 18.2% |
| 2014 Q4 | 1.34 Billion INR | 10.16% |
| 2014 Q3 | 1.22 Billion INR | 0.0% |
| 2013 FY | 4.4 Billion INR | 24.25% |
| 2012 FY | 3.54 Billion INR | 33.2% |
| 2011 FY | 2.66 Billion INR | 50.82% |
| 2010 FY | 1.76 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 2.27 Billion INR | -543.765% |
| Metropolis Healthcare Limited | 5.81 Billion INR | -151.513% |
| Thyrocare Technologies Limited | 2.5 Billion INR | -484.105% |
| Vijaya Diagnostic Centre Limited | 4.82 Billion INR | -203.104% |
| Vimta Labs Limited | 1.08 Billion INR | -1244.979% |